Literature DB >> 9917935

The etiology of premature rupture of the membranes.

W J Polzin1, K Brady.   

Abstract

The etiology of PROM is multifactorial. It is clear that maternal enzymes, maturational and mechanical forces, chorionicamniotic membrane phospholipid content, collagen disruption, amniotic cell cytokines induced by fetal signals, and bacterial phospholipases and collagenases all play major and interrelated roles. It is also clear that the production of oxytocic prostaglandins is a major, if not exclusive, common pathway leading to PROM and preterm delivery. The increasing awareness of the fetal role, i.e., fetal interleukins, fetal polymorphonuclear leukocytes and type V collagenase, make this area of research ripe for further investigation. The complex host defense mechanisms and biologic variability make any universal treatment impossible. Even with a specific etiology determined, the reduced availability of pharmacologic interventions for the fetal compartment portend suboptimal success. Therefore, it appears that continued research and aggressive measures to optimize the quality and availability of prenatal care are the best foci of our efforts.

Entities:  

Mesh:

Year:  1998        PMID: 9917935     DOI: 10.1097/00003081-199812000-00004

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  2 in total

1.  Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua.

Authors:  Charles J Lockwood; Paolo Toti; Felice Arcuri; Michael Paidas; Lynn Buchwalder; Graciela Krikun; Frederick Schatz
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

2.  Effects of subclinical hypothyroidism on maternal and perinatal outcomes during pregnancy: a single-center cohort study of a Chinese population.

Authors:  Liang-Miao Chen; Wen-Jun Du; Jie Dai; Qian Zhang; Guang-Xin Si; Hong Yang; En-Ling Ye; Qing-Shou Chen; Le-Chu Yu; Chi Zhang; Xue-Mian Lu
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.